Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Rattlesnake Beans, typically referring to *Mucuna pruriens*, are valued for L-DOPA, which converts to dopamine, and a rich profile of antioxidants like phenolics and flavonoids. These compounds contribute to its adaptogenic properties and neuroactive potential.
Reported Benefits (Provisional)
Origin & History
Rattlesnake Beans (Phaseolus vulgaris 'Rattlesnake') are a distinctive variety of common bean, a legume native to North and Central America. Historically cultivated by Indigenous tribes in the southwestern United States and Mexico, they thrive in warm, well-drained soils. These beans are valued in functional nutrition for their potent metabolic, immune, and cardiovascular-supporting properties.
Research Narrative (Provisional)
Preliminary research, including studies published on PubMed and ScienceDirect, indicates Rattlesnake Beans' potential for cardiovascular benefits through polyphenol content, metabolic enhancement, and immune support. Further investigation, including human clinical trials, is needed to fully elucidate their therapeutic applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Plant-based protein and essential amino acids - Dietary fiber and resistant starch - B-complex vitamins and folate - Minerals: Magnesium, potassium, calcium, iron - Phytochemicals: Isoflavones, polyphenols
Reported Mechanism (Provisional)
The primary mechanism involves L-DOPA (3,4-dihydroxy-L-phenylalanine), which is decarboxylated into dopamine, mainly in the periphery, influencing neurotransmission. Additionally, phenolic compounds and flavonoids exert antioxidant effects by scavenging reactive oxygen species (ROS), protecting cells from oxidative damage.
Clinical Narrative (Provisional)
While L-DOPA's efficacy in neurological conditions like Parkinson's disease is well-established through numerous clinical trials, specific human clinical trial data detailing general health benefits of *Mucuna pruriens* extracts, including sample sizes and comprehensive outcomes, are not extensively detailed in the provided research. Preliminary studies often focus on identifying bioactive compounds and elucidating their in vitro mechanisms. Further rigorous human clinical trials are warranted to fully substantiate traditional uses and health claims for *Mucuna pruriens* supplementation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.